276 related articles for article (PubMed ID: 33010974)
1. Androgens and hirsutism score of overweight women with polycystic ovary syndrome improved after vitamin D treatment: A randomized placebo controlled clinical trial.
Al-Bayyari N; Al-Domi H; Zayed F; Hailat R; Eaton A
Clin Nutr; 2021 Mar; 40(3):870-878. PubMed ID: 33010974
[TBL] [Abstract][Full Text] [Related]
2. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
Jafari-Sfidvajani S; Ahangari R; Hozoori M; Mozaffari-Khosravi H; Fallahzadeh H; Nadjarzadeh A
J Endocrinol Invest; 2018 May; 41(5):597-607. PubMed ID: 29110281
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.
Ardabili HR; Gargari BP; Farzadi L
Nutr Res; 2012 Mar; 32(3):195-201. PubMed ID: 22464806
[TBL] [Abstract][Full Text] [Related]
4. Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.
Karadağ C; Yoldemir T; Yavuz DG
J Obstet Gynaecol Res; 2018 Feb; 44(2):270-277. PubMed ID: 29094433
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D
Al-Bayyari N; Al-Zeidaneen S; Hailat R; Hamadneh J
Nutr Res; 2018 Nov; 59():65-71. PubMed ID: 30442234
[TBL] [Abstract][Full Text] [Related]
6. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome.
Jamilian M; Foroozanfard F; Rahmani E; Talebi M; Bahmani F; Asemi Z
Nutrients; 2017 Nov; 9(12):. PubMed ID: 29186759
[TBL] [Abstract][Full Text] [Related]
7. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome.
Ostadmohammadi V; Jamilian M; Bahmani F; Asemi Z
J Ovarian Res; 2019 Jan; 12(1):5. PubMed ID: 30665436
[TBL] [Abstract][Full Text] [Related]
9. Effect of 16-weeks vitamin D replacement on calcium-phosphate homeostasis in overweight and obese adults.
Mesinovic J; Mousa A; Wilson K; Scragg R; Plebanski M; de Courten M; Scott D; Naderpoor N; de Courten B
J Steroid Biochem Mol Biol; 2019 Feb; 186():169-175. PubMed ID: 30367939
[TBL] [Abstract][Full Text] [Related]
10. The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial.
Seyyed Abootorabi M; Ayremlou P; Behroozi-Lak T; Nourisaeidlou S
Gynecol Endocrinol; 2018 Jun; 34(6):489-494. PubMed ID: 29271278
[TBL] [Abstract][Full Text] [Related]
11. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
[TBL] [Abstract][Full Text] [Related]
12. Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.
Foroozanfard F; Jamilian M; Bahmani F; Talaee R; Talaee N; Hashemi T; Nasri K; Asemi Z; Esmaillzadeh A
Clin Endocrinol (Oxf); 2015 Dec; 83(6):888-94. PubMed ID: 26119844
[TBL] [Abstract][Full Text] [Related]
13. The effects of vitamin D and evening primrose oil co-supplementation on lipid profiles and biomarkers of oxidative stress in vitamin D-deficient women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
Nasri K; Akrami S; Rahimi M; Taghizadeh M; Behfar M; Mazandaranian MR; Kheiry A; Memarzadeh MR; Asemi Z
Endocr Res; 2018 Feb; 43(1):1-10. PubMed ID: 28742409
[TBL] [Abstract][Full Text] [Related]
14. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D
Al-Bayyari N; Hailat R; Subih H; Alkhalidy H; Eaton A
Br J Nutr; 2021 Jan; 125(2):139-146. PubMed ID: 32475360
[TBL] [Abstract][Full Text] [Related]
16. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome.
Pal L; Berry A; Coraluzzi L; Kustan E; Danton C; Shaw J; Taylor H
Gynecol Endocrinol; 2012 Dec; 28(12):965-8. PubMed ID: 22780885
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Vitamin D-K-Calcium Co-Supplementation on Endocrine, Inflammation, and Oxidative Stress Biomarkers in Vitamin D-Deficient Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Razavi M; Jamilian M; Karamali M; Bahmani F; Aghadavod E; Asemi Z
Horm Metab Res; 2016 Jul; 48(7):446-51. PubMed ID: 27050252
[TBL] [Abstract][Full Text] [Related]
19. Low vitamin D3 and high anti-Müllerian hormone serum levels in the polycystic ovary syndrome (PCOS): Is there a link?
Cappy H; Giacobini P; Pigny P; Bruyneel A; Leroy-Billiard M; Dewailly D; Catteau-Jonard S
Ann Endocrinol (Paris); 2016 Oct; 77(5):593-599. PubMed ID: 26997468
[TBL] [Abstract][Full Text] [Related]
20. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
